Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1250 Articles

Jon C. Ogg | Dec 12, 2016 at 11:10 AM EST

Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends

At the end of each year, investors look for opportunities and safe harbors to park their money for the year…

Jon C. Ogg | Dec 6, 2016 at 11:35 AM EST

The 11 Most Attractive Dow Stocks for 2017: Is DJIA 22,000 in the Cards?

It turns out that 11 of the 30 Dow Jones Industrial Average stocks have a consensus price target that calls…

Jon C. Ogg | Nov 29, 2016 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

The top analyst upgrades, downgrades and initiations seen on Tuesday morning include AK Steel, Celgene, Darden Restaurants, Delphi Automotive, Johnson…

Paul Ausick | Nov 28, 2016 at 4:01 PM EST

Nike, Visa Lead DJIA Down on Monday

November 28, 2016: Markets opened lower Monday after a long weekend of eating and shopping. There was no economic news…

Paul Ausick | Nov 24, 2016 at 8:39 AM EST

Target, Walmart Lead Top 10 Adopters of Solar Energy

Solar energy adoption among large U.S. corporations has grown from a total installed base of 300 megawatts (MW) in 2012…

Jon C. Ogg | Nov 14, 2016 at 5:10 PM EST

Major Changes in Warren Buffett & Berkshire Hathaway Stocks: American Airlines, Delta, Kinder Morgan, Wal-Mart, BNY Mellon and More

Outside of Warren Buffett being one of the richest men alive and being considered the greatest investor of modern times,…

Lee Jackson | Oct 30, 2016 at 10:10 AM EDT

Massive Energy Trade Highlights Insider Blue Chip Buying: Kinder Morgan, AT&T, Kimberly-Clark, IBM, Johnson & Johnson and More

With the busiest earnings week behind us, it appears some of the restriction windows at major U.S. corporations are starting…

Trey Thoelcke | Oct 21, 2016 at 7:45 AM EDT

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even…

Jon C. Ogg | Oct 19, 2016 at 10:35 AM EDT

5 Dow Stocks Outperforming Analyst Expectations for 2016

Of the 30 Dow Jones Industrial Average stocks, only five of them have outperformed analyst expectations this year, though some…

Chris Lange | Oct 18, 2016 at 9:15 AM EDT

Johnson & Johnson Remains Flat Despite Earnings Beat

Johnson & Johnson released a better-than-expected third-quarter report before the markets opened on Tuesday.

Chris Lange | Oct 17, 2016 at 12:15 PM EDT

What to Look for in Johnson & Johnson Earnings

Johnson & Johnson is expected to release its most recent earnings report before the markets open on Tuesday.

Chris Lange | Oct 16, 2016 at 10:20 AM EDT

Top DJIA Earnings Reports in the Week Ahead

A third of the Dow Jones Industrial Average is reporting quarterly results this week, which has the potential to push…

Jon C. Ogg | Oct 3, 2016 at 10:50 AM EDT

4 DJIA Stocks That Have Raised Dividends for Over 50 Years Straight

Here are four Dow stocks that have raised their dividends for 50 years or more, and that also appear to…

Jon C. Ogg | Sep 28, 2016 at 11:50 AM EDT

7 Giant Companies Raising Their Dividends for 25 Years or More

These corporate giants have stated or admitted on their own that they are in the 25-year dividend hike game.

Jon C. Ogg | Sep 26, 2016 at 10:50 AM EDT

New Crohn’s Disease Drug Approved by FDA

A unit of Johnson & Johnson has announced that the FDA has approved its Stelara for the treatment of moderately…

1 … 41 42 43 44 45 … 84

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends

The 11 Most Attractive Dow Stocks for 2017: Is DJIA 22,000 in the Cards?

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

Nike, Visa Lead DJIA Down on Monday

Target, Walmart Lead Top 10 Adopters of Solar Energy

Major Changes in Warren Buffett & Berkshire Hathaway Stocks: American Airlines, Delta, Kinder Morgan, Wal-Mart, BNY Mellon and More

Massive Energy Trade Highlights Insider Blue Chip Buying: Kinder Morgan, AT&T, Kimberly-Clark, IBM, Johnson & Johnson and More

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

5 Dow Stocks Outperforming Analyst Expectations for 2016

Johnson & Johnson Remains Flat Despite Earnings Beat

What to Look for in Johnson & Johnson Earnings

Top DJIA Earnings Reports in the Week Ahead

4 DJIA Stocks That Have Raised Dividends for Over 50 Years Straight

7 Giant Companies Raising Their Dividends for 25 Years or More

New Crohn’s Disease Drug Approved by FDA

DGRO vs. VIG: Which Dividend-Growth ETF Compounds Your Income Faster?

What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality

Why Arm Is a Strong Buy Despite the 35% Pullback From Peak Levels

What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality

What Happens When Medicare Premiums Are No Longer Your Problem?

DGRO vs. VIG: Which Dividend-Growth ETF Compounds Your Income Faster?

What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends

The 11 Most Attractive Dow Stocks for 2017: Is DJIA 22,000 in the Cards?

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

Nike, Visa Lead DJIA Down on Monday

Target, Walmart Lead Top 10 Adopters of Solar Energy

Major Changes in Warren Buffett & Berkshire Hathaway Stocks: American Airlines, Delta, Kinder Morgan, Wal-Mart, BNY Mellon and More

Massive Energy Trade Highlights Insider Blue Chip Buying: Kinder Morgan, AT&T, Kimberly-Clark, IBM, Johnson & Johnson and More

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

5 Dow Stocks Outperforming Analyst Expectations for 2016

Johnson & Johnson Remains Flat Despite Earnings Beat

What to Look for in Johnson & Johnson Earnings

Top DJIA Earnings Reports in the Week Ahead

4 DJIA Stocks That Have Raised Dividends for Over 50 Years Straight

7 Giant Companies Raising Their Dividends for 25 Years or More

New Crohn’s Disease Drug Approved by FDA

DGRO vs. VIG: Which Dividend-Growth ETF Compounds Your Income Faster?

What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality

Why Arm Is a Strong Buy Despite the 35% Pullback From Peak Levels

Featured Reads

What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality

What Happens When Medicare Premiums Are No Longer Your Problem?